Drugs and Devices

FDA allows marketing of first device to prevent migraine headaches

On March 11, the U.S. Food and Drug Administration (FDA) allowed marketing of the first device as a preventative treatment for migraine headaches. This is also the first transcutaneous electrical nerve stimulation device specifically authorized for use before the onset of pain. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares